Skip to main content

Calcium Carbonate-Induced Effects on Serum Ca X P Product and Serum Creatinine in Renal Failure: A Retrospective Study

  • Chapter
Phosphate and Minerals in Health and Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 128))

Abstract

Several lines of evidence, which we have summarized recently elsewhere (1) have lent support to the hypothesis, stated previously by us (2) as well as others, that progression of chronic renal failure may be in part attributable to the vicious circle depicted in Figure 1. The most impressive evidence pertinent to this hypothesis consists of clinical studies in which phosphate intake was restricted early in the course of chronic renal failure in man, in order to prevent renal osteodystrophy (3, 4). An unexpected result of these studies was that progression of renal insufficiency was much slower than in comparable series of patients. In addition, phosphate restriction can prevent the progression to terminal uremia of certain types of experimentally induced renal failure in rats (5, 6).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Walser, Does dietary therapy have a role in the pre-dialysis patient? Am. J. Clin. Nutr. In Press (1979).

    Google Scholar 

  2. M. Walser, Conservative management of chronic renal failure, Chapter 39 in: “The Kidney”, B. Brenner and F, Rector, eds., W. B. Saunders, Philadelphia (1976).

    Google Scholar 

  3. W. J. Johnson, R. S. Goldsmith, J. Jowsey, P, P. Frohnert, and C. D. Arnaud, The influence of maintaining normal serum phosphate and calcium on renal osteodystrophy, in; “Vitamin D and Problems Related to Uremic Bone Disease”, Ar W. Norman, K. Schaefer, H. G. Grigoleit, D. von Herrath, and E. Ritz. Walter de Gruyter, Berlin/New York (1975).

    Google Scholar 

  4. G. Maschio, N. Tessitore, A. D’Angelo, E. Bonucci, A. Lupo, E. Valvo, C. Loschiavo, A. Fabris, P. Morachiello, G. Previato, and E. Fiaschi, Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteo-dystrophy. Am, J. Clin. Nutr. In Press 1979 ).

    Google Scholar 

  5. L. S. Ibels, A. C. ALfrey, A. L. Haut, and W. E. Huffer, Preservation of function in experimental renal disease by dietary restriction of phosphate. New Engl. J. Med. 298: 122 (1978).

    Article  PubMed  CAS  Google Scholar 

  6. A. C. Alfrey, M. L. Karlinsky, and L. H. Haut. Prevention of functional deterioration in experimental renal disease by dietary phosphorus restriction, in: Proc. IVth International Workshop on Phosphate and Other Minerals, S. Massry, ed. Plenum Publishers, New York (In Press).

    Google Scholar 

  7. S. Winkler, A. S. Brickman, E. G. C. Wong, D. J. Sherrard, R. B. Miller, C. M. Bennett, and J. W. Coburn, Hypercalcemia during treatment with 1,25-hydroxy-vitamin D-3: analysis of 30 cases. Kidney Int. 14: 667 (1978).

    Google Scholar 

  8. B. F. C. Nordin, Vitamin D analogues and renal function, Lancet 2: 1259 (1978).

    Article  Google Scholar 

  9. C. Christiansen, M. S. Christiansen, B. Hartnal, F. Melsen, I. Transbol, and P. Rodbro, Vitamin D analogues and renal function. Lancet 1: 50 (1979).

    Article  PubMed  CAS  Google Scholar 

  10. S. S. Franklin, A. Gordon, C. R. Kleeman, and M. D. Maxwell. The use of a balanced low protein diet in the treatment of chronic renal failure. JAMA 202: 141 (1967).

    Article  Google Scholar 

  11. M. M. Popovtzer, and J. B. Robinette, Effect of oral calcium carbonate on urinary excretion on Ca, Na, and Mg in advanced renal disease. Proc. Soc. Exp. Biol. Med. 145: 222 (1974).

    PubMed  CAS  Google Scholar 

  12. E. M. Clarkson, S. J. McDonald, and H. E. DeWardener, The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure. Clin. Sci. 30: 425 (1966).

    PubMed  CAS  Google Scholar 

  13. S. J. McDonald, E. M. Clarkson, and H. E. DeWardener, The effect of a large intake of calcium citrate in normal subjects and patients with chronic renal failure. Clin. Sci. 26: 27 (1964).

    PubMed  CAS  Google Scholar 

  14. D. L. Makoff, A. Gordon, S. S. Franklin, A. R. Gerstein, and M. H. Maxwell, Chronic calcium carbonate therapy in uremia, Arch. Intern. Med. 123: 15 (1969).

    Article  PubMed  CAS  Google Scholar 

  15. G. Berlyne, Calcium carbonate treatment of uremic acidosis, Isr. J. Med. Sci. 7: 1235 (1971).

    PubMed  CAS  Google Scholar 

  16. W. E. Mitch, G. Buffington, J. Lemann, and M. Walser, A simple method of estimating progression of chronic renal failure, Lancet 2: 1326 (1976)

    Article  PubMed  CAS  Google Scholar 

  17. W, E. Rutherford, J. Blondin, J. P. Miller, A. S. Greenwalt, and J. D. Vavra, Chronic progressive renal disease: Rate of change of serum creatinine concentration, Kidney Int. 11; 62 (1977).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Plenum Press, New York

About this chapter

Cite this chapter

Walser, M. (1980). Calcium Carbonate-Induced Effects on Serum Ca X P Product and Serum Creatinine in Renal Failure: A Retrospective Study. In: Massry, S.G., Ritz, E., Jahn, H. (eds) Phosphate and Minerals in Health and Disease. Advances in Experimental Medicine and Biology, vol 128. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9167-2_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9167-2_33

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9169-6

  • Online ISBN: 978-1-4615-9167-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics